Welcome to LookChem.com Sign In|Join Free
  • or
(17beta)-13-Ethyl-17-hydroxy-11-methylenegon-4-en-3-one is a complex organic compound that belongs to the steroid family. It features a four-ring carbon structure with various functional groups attached, exhibiting properties typical of other similar hydrocarbon structures. (17beta)-13-Ethyl-17-hydroxy-11-methylenegon-4-en-3-one is likely to have specific applications in the field of biochemistry or medicinal chemistry, and its exact structure and properties can be predicted and studied using appropriate computer modeling and laboratory techniques. However, due to its complicated name, the specific uses, properties, and occurrences of this chemical may not be widely documented or it may be known under another more common name.

220332-82-1

Post Buying Request

220332-82-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

220332-82-1 Usage

Uses

Used in Biochemistry Research:
(17beta)-13-Ethyl-17-hydroxy-11-methylenegon-4-en-3-one is used as a research compound for studying its chemical properties and potential interactions with biological systems. Its complex structure and functional groups make it a valuable subject for understanding the behavior of similar compounds in biochemical processes.
Used in Medicinal Chemistry:
(17beta)-13-Ethyl-17-hydroxy-11-methylenegon-4-en-3-one is used as a lead compound in the development of new pharmaceuticals. Its unique structure and properties may offer potential therapeutic applications, and researchers can explore its interactions with biological targets to design more effective drugs.
Used in Drug Design and Development:
(17beta)-13-Ethyl-17-hydroxy-11-methylenegon-4-en-3-one is used as a template for designing new drugs, particularly in the field of steroidal compounds. Its structure can be modified to create derivatives with improved pharmacological properties, such as increased potency, selectivity, or reduced side effects.
Used in Analytical Chemistry:
(17beta)-13-Ethyl-17-hydroxy-11-methylenegon-4-en-3-one is used as a reference compound in analytical chemistry for the development and validation of analytical methods. Its complex structure and properties can be used to test the accuracy and reliability of various analytical techniques, such as chromatography, mass spectrometry, or nuclear magnetic resonance (NMR) spectroscopy.

Check Digit Verification of cas no

The CAS Registry Mumber 220332-82-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,0,3,3 and 2 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 220332-82:
(8*2)+(7*2)+(6*0)+(5*3)+(4*3)+(3*2)+(2*8)+(1*2)=81
81 % 10 = 1
So 220332-82-1 is a valid CAS Registry Number.

220332-82-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name (8S,9S,10R,14S)-13-ethyl-17-hydroxy-11-methylidene-1,2,6,7,8,9,10,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one

1.2 Other means of identification

Product number -
Other names (8S,9S,10R,14S)-13-Ethyl-17-hydroxy-11-methylene-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:220332-82-1 SDS

220332-82-1Relevant academic research and scientific papers

Preparation method for etonogestrel and desogestrel important intermediate

-

, (2018/12/13)

The invention discloses a preparation method for an etonogestrel and desogestrel important intermediate. The preparation method is characterized in that the intermediate is prepared from a compound shown as a formula (2) which is taken as an initial raw material. The preparation method obtains the object product in high yield through five steps, and the whole process is mild in reaction condition,low in danger and simple in operation. The preparation method is much better than known literature processes no matter from respects of atomic economy, safety and price cost or the respect of storageand transportation, and the problems of high toxicity and non-stabilization of used reagents and intermediate products and severe pollution on environment of by-products can be avoided. The prepareddesogestrel and etonogestrel important intermediate (1) is mild in reaction condition, relatively complete in reaction, high in chemical selectivity and high in reaction yield, and solvents can be recycled, so that convenient industrial implementation can be realized. Reaction general formulas are shown as follows.

TOTAL SYNTHESIS OF ENANTIOPURE DESOGESTREL

-

Page/Page column 34-35, (2009/04/25)

The present invention relates to a total synthesis of desogestrel and derivatives thereof, and to intermediate compounds of this synthesis.

Enantioselective total synthesis of the oral contraceptive desogestrel by a double heck reaction

Tietze, Lutz F.,Krimmelbein, Ilga K.

experimental part, p. 1541 - 1551 (2009/04/04)

A novel enantioselective total synthesis of the oral contraceptive desogestrel (2) is described, in which the tetracyclic steroid core is formed by a sequence of two consecutive Heck reactions. Conversion of the known enantiopure diketone 7 led to the chiral bicycle 6 which was used for a diastereoselective intermolecular Heck reaction with vinyliodide 5 to give 15. In the following intramolecular Heck reaction, the tetracyclic ring system was formed to give 4, from which the synthesis of desogestrel (2) was furnished.

A short enantioselective total synthesis of the third-generation oral contraceptive desogestrel

Corey,Huang, Alan X.

, p. 710 - 714 (2007/10/03)

Desogestrel (1) has been synthesized enantioselectively by a 14-step process from the known and readily available precursor 3, as outlined in Chart 2. At the heart of this process is the short, convergent, and stereocontrolled method for forming the tetracyclic ring system and the critical 11-exomethylene function, that is, the sequence of steps 6 → 8 → → 12. All steps of the synthesis proceed in good yield.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 220332-82-1